02 July 2020>: Clinical Research
Nuclear Factor κB/MicroRNA-155 Upregulates the Expression Pattern of Cytokines in Regulating the Relapse of Chronic Sinusitis with Nasal Polyps and the Underlying Mechanism of Glucocorticoid
Jianbin Du 1BCE , Haijun Lv 2BC , Xin Dou 3BC , Zhongsheng Cao 1ADEF*DOI: 10.12659/MSM.923618
Med Sci Monit 2020; 26:e923618
Table 1 Clinical characteristics of study patients.
Items | Control | CRSsNP | Non-Eos CRSwNP | Eos CRSwNP |
---|---|---|---|---|
Number | 30 | 25 | 25 | 25 |
Gender (Male/Female) | 18/12 | 17/8 | 13/12 | 16/9 |
Age (years) | 38.8±7.5 | 40.4±8.3 | 40.8±8.9 | 42.1±8.2 |
Positive for Phadiatop, n (%) | 1 (3.3%) | 3 (12.0%) | 5 (20.0%) | 6 (24.0%) |
Positive for asthma, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Smoking history, n (%) | 8 (26.7%) | 7 (25.0%) | 10 (40.0%) | 9 (36.0%) |
Aspirin intolerance triad | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
CRSsNP – chronic rhinosinusitis without nasal polyps; Non-Eos CRSwNP – non-eosinophilic chronic rhinosinusitis with nasal polyps; Eos CRSwNP – eosinophilic chronic rhinosinusitis with nasal polyps. |